Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Female Contraception - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Female Contraception (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Contraception and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
92 pages
Gaucher Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gaucher Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Gaucher Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
105 pages
Meningitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Meningitis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Meningitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
76 pages
Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Multiple Myeloma (Kahler Disease) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Multiple Myeloma (Kahler Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
2289 pages
Pertussis (Whooping Cough) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Pertussis (Whooping Cough) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pertussis (Whooping Cough) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
127 pages
Bullous Pemphigoid - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bullous Pemphigoid (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Bullous Pemphigoid and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
139 pages
Globoid Cell Leukodystrophy (Krabbe Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Globoid Cell Leukodystrophy (Krabbe Disease) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Globoid Cell Leukodystrophy (Krabbe Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
77 pages
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Ornithine-Transcarbamylase Deficiency (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ornithine-Transcarbamylase Deficiency and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
53 pages
Graves Diseases - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Graves Diseases (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Graves Diseases and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
75 pages
Heart Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... therapeutics under Development by Companies/Universities/Institutes, Heart Transplant Rejection - Pipeline Review, H1 2018 Reference Code: GMDHC10549IDBPublication Date: June 2018 Heart Transplant Rejection (Immunology) pipeline guide helps in identifying and tracking emerging players ...
June 2020
33 pages
Hyperinsulinemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hyperinsulinemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperinsulinemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
77 pages
Influenza A Virus, H7N9 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H7N9 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
136 pages
Merkel Cell Carcinoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Merkel Cell Carcinoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Merkel Cell Carcinoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
535 pages
Middle East Respiratory Syndrome (MERS) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Middle East Respiratory Syndrome (MERS) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Middle East Respiratory Syndrome (MERS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
134 pages
Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H1 2020
US$ 2,000.00
... Neurofibromatoses Type I (Von Recklinghausen’s Disease) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neurofibromatoses Type I (Von Recklinghausen’s Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
June 2020
69 pages
Prosthetic joint infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Prosthetic joint infections (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prosthetic joint infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
66 pages
Tinea pedis (Athlete Foot) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Tinea pedis (Athlete Foot) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tinea pedis (Athlete Foot) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
32 pages
Usher Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Usher Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Usher Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
60 pages
Wilson Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Wilson Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Wilson Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
65 pages
Zika Virus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Zika Virus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Zika Virus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
June 2020
274 pages
Presbyopia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Presbyopia (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Presbyopia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
June 2020
60 pages
5' Nucleotidase - Pipeline Review, H1 2020
US$ 3,500.00
5' Nucleotidase - Pipeline Review, H1 2020 SUMMARY According to the recently published report '5' Nucleotidase – Pipeline Review, H1 2020'; 5' Nucleotidase (Ecto 5' Nucleotidase or CD73 or NT5E or E...
June 2020
109 pages
Alpha 2C Adrenergic Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Alpha 2C Adrenergic Receptor - Pipeline Review, H1 2020 SUMMARY Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) – Alpha-2C adrenergic recep...
June 2020
50 pages
Alpha N-Acetylglucosaminidase - Pipeline Review, H1 2020
US$ 3,500.00
Alpha N-Acetylglucosaminidase - Pipeline Review, H1 2020 SUMMARY Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1.50) pipeline Target constitutes close to 8 molecul...
June 2020
54 pages
Alpha Synuclein - Pipeline Review, H1 2020
US$ 3,500.00
Alpha Synuclein - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Alpha Synuclein – Pipeline Review, H1 2020'; Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non...
June 2020
150 pages
Bcl 2 Like Protein 1 - Pipeline Review, H1 2020
US$ 3,500.00
Bcl 2 Like Protein 1 - Pipeline Review, H1 2020 SUMMARY Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) – Bcl-2-like protein 1 is a protein encoded by the BCL2L1 gene. It belongs t...
June 2020
61 pages
Ephrin Type B Receptor 4 - Pipeline Review, H1 2020
US$ 3,500.00
Ephrin Type B Receptor 4 - Pipeline Review, H1 2020 SUMMARY Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constit...
June 2020
49 pages
Integrin Alpha 4 - Pipeline Review, H1 2020
US$ 3,500.00
Integrin Alpha 4 - Pipeline Review, H1 2020 SUMMARY Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) pipeline Target constitutes close to 18 molecules. Th...
June 2020
105 pages
Integrin Beta 7 - Pipeline Review, H1 2020
US$ 3,500.00
Integrin Beta 7 - Pipeline Review, H1 2020 SUMMARY Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) – Integrin beta-7 is an integrin protein encoded by the ITGB7 gene. It interacts with t...
June 2020
64 pages
Leptin Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Leptin Receptor - Pipeline Review, H1 2020 SUMMARY Leptin Receptor (HuB219 or OB Receptor or CD295 or LEPR) pipeline Target constitutes close to 8 molecules. The latest report Leptin Receptor – Pipe...
June 2020
54 pages
P2X Purinoceptor 3 - Pipeline Review, H1 2020
US$ 3,500.00
P2X Purinoceptor 3 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'P2X Purinoceptor 3 – Pipeline Review, H1 2020'; P2X Purinoceptor 3 (P2RX3) pipeline Target constitut...
June 2020
67 pages
Smoothened Homolog - Pipeline Review, H1 2020
US$ 3,500.00
Smoothened Homolog - Pipeline Review, H1 2020 SUMMARY Smoothened Homolog (Protein Gx or SMO) pipeline Target constitutes close to 14 molecules. Out of which approximately 11 molecules are developed...
June 2020
90 pages
Survival Motor Neuron Protein - Pipeline Review, H1 2020
US$ 3,500.00
Survival Motor Neuron Protein - Pipeline Review, H1 2020 SUMMARY Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) – Survival of motor neuron or survival motor neuron (S...
June 2020
92 pages
Toll Like Receptor 4 - Pipeline Review, H1 2020
US$ 3,500.00
Toll Like Receptor 4 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Toll Like Receptor 4 – Pipeline Review, H1 2020'; Toll Like Receptor 4 (hToll or CD284 or TLR4) pi...
June 2020
131 pages
Tyrosine Protein Kinase CSK - Pipeline Review, H1 2020
US$ 3,500.00
Tyrosine Protein Kinase CSK - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Tyrosine Protein Kinase CSK – Pipeline Review, H1 2020'; Tyrosine Protein Kinase CSK (C Src...
June 2020
96 pages
Eastern Equine Encephalitis - Pipeline Review, H1 2020
US$ 2,000.00
Eastern Equine Encephalitis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eastern Equine Encephalitis - Pipeline Review, H1 202...
June 2020
41 pages
Hyperphosphatemia - Pipeline Review, H1 2020
US$ 2,000.00
Hyperphosphatemia - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia - Pipeline Review, H1 2020, provides an overv...
June 2020
80 pages
